The impact of application of embryonic membrane in surgery to remove tonsils

Not Applicable

• Conditions: Tonsillectomy.; Hypertrophy of tonsils, Hypertrophy of tonsils with hypertrophy of adenoids; J35.1, J35

• Registration Number: IRCT20131123015496N21
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with 18 years of age or older
Patients undergoing tonsillectomy for indications of recurrent tonsillitis or tonsillar hypertrophy.

Exclusion Criteria

Patients who had previous peritonsillar abscess, acute infection, coagulatory problems, major organ disease like congestive heart failure, renal failure, hepatic failure or any other internal problems effecting the hemostasis condition

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score intensity after tonsillectomy. Timepoint: Three times a day; before breakfast, lunch, dinner for 7 days after surgery. Method of measurement: Visual Analog Scale (VAS)-by patient.;Post-tonsillectomy bleeding. Timepoint: within 14 days after surgery. Method of measurement: Observation by ENT specialist.

Secondary Outcome Measures

Name	Time	Method
Percentage of wound healing. Timepoint: 5, 10 and 15 days after surgery. Method of measurement: Observation by ENT specialist.